- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6536
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Emerging Immunotherapies for Parkinson Disease ; day:11 ; month:12 ; year:2018 ; pages:1-16
Neurology and Therapy ; (11.12.2018), 1-16
- Urheber
-
Zella, Samis M. A.
Metzdorf, Judith
Ciftci, Emine
Ostendorf, Friederike
Muhlack, Siegfried
Gold, Ralf
Tönges, Lars
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40120-018-0122-z
- URN
-
urn:nbn:de:101:1-2019012715030687127792
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zella, Samis M. A.
- Metzdorf, Judith
- Ciftci, Emine
- Ostendorf, Friederike
- Muhlack, Siegfried
- Gold, Ralf
- Tönges, Lars
- SpringerLink (Online service)
Ähnliche Objekte (12)
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Potentials and limitations of current and emerging immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease
Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review
Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Harnessing bioengineered myeloid progenitors for precision immunotherapies
Molecular imaging biomarkers for cell-based immunotherapies
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Potentials and limitations of current and emerging immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease
Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review
Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Harnessing bioengineered myeloid progenitors for precision immunotherapies
Molecular imaging biomarkers for cell-based immunotherapies
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Potentials and limitations of current and emerging immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease
Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review
Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Harnessing bioengineered myeloid progenitors for precision immunotherapies